Tcr2 Therapeutics Buy Hold or Sell Recommendation
| TCRRDelisted Stock | USD 1.48 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Tcr2 Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Tcr2 Therapeutics given historical horizon and risk tolerance towards Tcr2 Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Tcr2 Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Note, we conduct extensive research on individual companies such as Tcr2 and provide practical buy, sell, or hold advice based on investors' constraints. Tcr2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Tcr2 |
Execute Tcr2 Therapeutics Buy or Sell Advice
The Tcr2 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Tcr2 Therapeutics. Macroaxis does not own or have any residual interests in Tcr2 Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Tcr2 Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Tcr2 Therapeutics Trading Alerts and Improvement Suggestions
| Tcr2 Therapeutics is not yet fully synchronised with the market data | |
| Tcr2 Therapeutics may become a speculative penny stock | |
| Tcr2 Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (151.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tcr2 Therapeutics currently holds about 175.99 M in cash with (101.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Tcr2 Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tcr2 analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tcr2 analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Tcr2 Therapeutics Returns Distribution Density
The distribution of Tcr2 Therapeutics' historical returns is an attempt to chart the uncertainty of Tcr2 Therapeutics' future price movements. The chart of the probability distribution of Tcr2 Therapeutics daily returns describes the distribution of returns around its average expected value. We use Tcr2 Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Tcr2 Therapeutics returns is essential to provide solid investment advice for Tcr2 Therapeutics.
| Mean Return | 0.39 | Value At Risk | -6.25 | Potential Upside | 5.77 | Standard Deviation | 5.44 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Tcr2 Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition or disposition of Tcr2 Therapeutics securities by Mpm Sunstates Fund Lp [view details]
Tcr2 Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Tcr2 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Tcr2 Therapeutics Buy or Sell Advice
When is the right time to buy or sell Tcr2 Therapeutics? Buying financial instruments such as Tcr2 Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Tcr2 Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Copper Thematic Idea Now
Copper
Companies involved in production of copper. The Copper theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Copper Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Tcr2 Stock
If you are still planning to invest in Tcr2 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tcr2 Therapeutics' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |